Cancer is increasingly common among HIV patients given improved survival

Achenbach, Chad J

Althoff, Keri N

Brooks, John T

Burchell, Ann N

D'Souza, Gypsyamber

Dubrow, Robert

Engels, Eric A

Gill, M John

Goedert, James J

Hessol, Nancy A

Hogg, Robert

Horberg, Michael A

Jing, Yuezhou

Justice, Amy C

Kirk, Gregory D

Kitahata, Mari M

Korthuis, Philip T

Lau, Bryan

Mathews, William C

Mayor, Angel

Modur, Sharada P

Moore, Richard D

Napravnik, Sonia

North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS

Novak, Richard M

Patel, Pragna

Rachlis, Anita R

Silverberg, Michael J

Sterling, Timothy R

Willig, James H

BackgroundCancer is increasingly common among persons with HIV.ObjectiveTo examine calendar trends in cumulative cancer incidence and hazard rate by HIV status.DesignCohort study.SettingNorth American AIDS Cohort Collaboration on Research and Design during 1996 to 2009.Participants86 620 persons with HIV and 196 987 uninfected adults.MeasurementsCancer type-specific cumulative incidence by age 75 years and calendar trends in cumulative incidence and hazard rates, each by HIV status.ResultsCumulative incidences of cancer by age 75 years for persons with and without HIV, respectively, were as follows: Kaposi sarcoma, 4.4% and 0.01%; non-Hodgkin lymphoma, 4.5% and 0.7%; lung cancer, 3.4% and 2.8%; anal cancer, 1.5% and 0.05%; colorectal cancer, 1.0% and 1.5%; liver cancer, 1.1% and 0.4%; Hodgkin lymphoma, 0.9% and 0.09%; melanoma, 0.5% and 0.6%; and oral cavity/pharyngeal cancer, 0.8% and 0.8%. Among persons with HIV, calendar trends in cumulative incidence and hazard rate decreased for Kaposi sarcoma and non-Hodgkin lymphoma. For anal, colorectal, and liver cancer, increasing cumulative incidence, but not hazard rate trends, were due to the decreasing mortality rate trend (-9% per year), allowing greater opportunity to be diagnosed. Despite decreasing hazard rate trends for lung cancer, Hodgkin lymphoma, and melanoma, cumulative incidence trends were not seen because of the compensating effect of the declining mortality rate.LimitationSecular trends in screening, smoking, and viral co-infections were not evaluated.ConclusionCumulative cancer incidence by age 75 years, approximating lifetime risk in persons with HIV, may have clinical utility in this population. The high cumulative incidences by age 75 years for Kaposi sarcoma, non-Hodgkin lymphoma, and lung cancer support early and sustained antiretroviral therapy and smoking cessation

eScholarship - University of California

English

Cumulative Incidence of Cancer Among Persons With HIV in North America A Cohort Study

Silverberg, Michael J.

Achenbach, Chad J.

Althoff, Keri N.

Engels, Eric A.

Hessol, Nancy A.

Brooks, John T.

Burchell, Ann N.

Gill, M. John

Goedert, James J.

Horberg, Michael A.

Kirk, Gregory D.

Kitahata, Mari M.

Korthuis, Philip T.

Mathews, William C.

Modur, Sharada P.

Novak, Richard M.

Rachlis, Anita R.

Sterling, Timothy R.

Willig, James H.

Justice, Amy C.

Moore, Richard D.

Carolina Digital Repository

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study

https://cdr.lib.unc.edu/downloads/bk128j156

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study

Abstract

Similar works

Full text

Available Versions

eScholarship - University of California

Carolina Digital Repository